Accexible: Clinical Trials

8 trials sponsored by Accexible, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Accexible: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AcceXible Speech-Based Screening for Depression and Anxiety in University Students (UAQ, Mexico)
Accexible - Depression - Major Depressive Disorder, Anxiety
Not yet recruitingAccexible802026-09-052026-05-11
AcceXible Speech-Based Screening for Depression and Anxiety in University Students (BUAP, Mexico)
AcceXible - Depression - Major Depressive Disorder, Anxiety
CompletedAccexible7852024-11-202026-04-27
Validation of Accexible Screening and Self-Administered Activities for Emotional Well-Being in a University Hospital (UaDEC)
AcceXible - Depression - Major Depressive Disorder, Anxiety
CompletedAccexible9022024-03-192026-05-11
Validation of Accexible as a Tool for Screening and Monitoring Depression.
Accexible - Major Depressive Disorder (MDD)
CompletedAccexible1662023-07-102026-03-25
UK Validation of the Automated "AcceXible" Speech Analysis Software
Accexible - Mild Cognitive Impairment and Dementia
CompletedAccexible2212022-11-182026-04-23
Accexible Speech Analysis for MCI Detection and Monitoring in Colombia
Accexible - MCI
CompletedAccexible1142022-05-222026-05-08
Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care
Speech analysis - Mild Cognitive Impairment, Dementia
Not applicableCompletedAccexible2732021-05-172026-04-01
Short-term Automated Longitudinal Analysis of Speech and Language in Cognitive Impairment
Speech analysis - Mild Cognitive Impairment, Dementia
Not applicableCompletedAccexible1962019-01-012026-03-25

Conditions studied

Anxiety Disorders (3)  ·  Cognitive Dysfunction (3)  ·  Dementia (3)  ·  Depression (3)  ·  Depressive Disorder, Major (1)

Countries

Mexico (3)  ·  Spain (3)  ·  Colombia (1)  ·  United Kingdom (1)